Search Results - "Yokoyama, Masayuki "

Refine Results
  1. 1

    Toxicity and immunogenicity concerns related to PEGylated-micelle carrier systems: a review by Shiraishi, Kouichi, Yokoyama, Masayuki

    “…Polymeric-micelle carrier systems have emerged as a novel drug-carrier system and have been actively studied for anticancer drug targeting. In contrast,…”
    Get full text
    Journal Article
  2. 2

    A polymeric micelle magnetic resonance imaging (MRI) contrast agent reveals blood–brain barrier (BBB) permeability for macromolecules in cerebral ischemia-reperfusion injury by Shiraishi, Kouichi, Wang, Zuojun, Kokuryo, Daisuke, Aoki, Ichio, Yokoyama, Masayuki

    Published in Journal of controlled release (10-05-2017)
    “…Blood–brain barrier (BBB) opening is a key phenomenon for understanding ischemia-reperfusion injuries that are directly linked to hemorrhagic transformation…”
    Get full text
    Journal Article
  3. 3

    Stability evaluation of Gd chelates for macromolecular MRI contrast agents by Yokoyama, Masayuki, Shiraishi, Kouichi

    Published in Magma (New York, N.Y.) (01-08-2020)
    “…Objective We try to establish designs for the macromolecular agents possessing high Gd 3+ -chelating stability, because free Gd 3+ ion released from Gd…”
    Get full text
    Journal Article
  4. 4

    Partial Modification of Electron-withdrawing Groups in Thermally-activated Delayed Fluorescence Materials Aimed to Improve Efficiency and Stability by Yokoyama, Masayuki, Tsuchiya, Youichi, Nakanotani, Hajime, Adachi, Chihaya

    Published in Chemistry letters (05-10-2020)
    “…Highly efficient and stable blue-green thermally-activated delayed fluorescence (TADF) molecules with trifluoromethyl (CF3) groups were developed. Partial…”
    Get full text
    Journal Article
  5. 5

    Drug targeting with nano-sized carrier systems by Yokoyama, Masayuki

    Published in Journal of artificial organs (01-08-2005)
    “…This paper discusses the present status of, and future perspectives on, drug targeting through the bloodstream by describing the drug targeting concept, its…”
    Get full text
    Journal Article
  6. 6

    Hydrophobic blocks of PEG-conjugates play a significant role in the accelerated blood clearance (ABC) phenomenon by Shiraishi, Kouichi, Hamano, Mikiko, Ma, Huili, Kawano, Kumi, Maitani, Yoshie, Aoshi, Taiki, Ishii, Ken J., Yokoyama, Masayuki

    Published in Journal of controlled release (10-02-2013)
    “…Injections of poly(ethylene glycol)-modified liposomes (PEG-liposomes) cause rapid clearance of the second dose of PEG-liposomes. This phenomenon is known as…”
    Get full text
    Journal Article
  7. 7

    Preparation and Commissioning for the LHD Deuterium Experiment by Osakabe, Masaki, Isobe, Mitsutaka, Tanaka, Masahiro, Motojima, Gen, Tsumori, Katsuyoshi, Yokoyama, Masayuki, Morisaki, Tomohiro, Takeiri, Yasuhiko

    Published in IEEE transactions on plasma science (01-06-2018)
    “…The deuterium experiment started from March 2017 on the large helical device (LHD) as a part of the LHD high-performance upgrade project. The objectives of the…”
    Get full text
    Journal Article
  8. 8

    Extending the total neutron emission rate of steady-state deuterium large helical plasma guided by a data-driven approach by Ogawa, Kunihiro, Isobe, Mitsutaka, Yokoyama, Masayuki

    Published in Fusion engineering and design (01-06-2021)
    “…•A trial for extending the total neutron emission rate was performed in steady state deuterium large helical plasma.•A quantitative guidance is acquired by…”
    Get full text
    Journal Article
  9. 9

    Impact of the Hydrophilicity of Poly(sarcosine) on Poly(ethylene glycol) (PEG) for the Suppression of Anti-PEG Antibody Binding by Maiti, Debabrata, Yokoyama, Masayuki, Shiraishi, Kouichi

    Published in ACS omega (13-08-2024)
    “…A method of poly­(ethylene glycol) (PEG) conjugation is known as PEGylation, which has been employed to deliver therapeutic drugs, proteins, or nanoparticles…”
    Get full text
    Journal Article
  10. 10

    Preparation and in vivo imaging of PEG-poly(L-lysine)-based polymeric micelle MRI contrast agents by Shiraishi, Kouichi, Kawano, Kumi, Minowa, Takuya, Maitani, Yoshie, Yokoyama, Masayuki

    Published in Journal of controlled release (21-05-2009)
    “…A polymeric micelle drug carrier system was applied to the targeting of an MRI (magnetic resonance imaging) contrast agent. A block copolymer, PEG-…”
    Get full text
    Journal Article
  11. 11

    Determination of polymeric micelles' structural characteristics, and effect of the characteristics on pharmacokinetic behaviors by Shiraishi, Kouichi, Sanada, Yusuke, Mochizuki, Shinichi, Kawano, Kumi, Maitani, Yoshie, Sakurai, Kazuo, Yokoyama, Masayuki

    Published in Journal of controlled release (10-04-2015)
    “…We evaluated structural factors characterizing PEG-b-P(Asp-Bzl) micelles including core size, aggregation number (Nagg), and core surface PEG density by means…”
    Get full text
    Journal Article
  12. 12

    Exploring the relationship between anti-PEG IgM behaviors and PEGylated nanoparticles and its significance for accelerated blood clearance by Shiraishi, Kouichi, Kawano, Kumi, Maitani, Yoshie, Aoshi, Taiki, Ishii, Ken J., Sanada, Yusuke, Mochizuki, Shinichi, Sakurai, Kazuo, Yokoyama, Masayuki

    Published in Journal of controlled release (28-07-2016)
    “…Surface PEGylation on nanoparticles has greatly helped prolong their blood circulation half-lives. However, The injection of PEGylated nanoparticles into mice…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Efficacy and safety of upadacitinib over 84 weeks in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE) by Kameda, Hideto, Takeuchi, Tsutomu, Yamaoka, Kunihiro, Oribe, Motohiro, Kawano, Mitsuhiro, Yokoyama, Masayuki, Pangan, Aileen L, Konishi, Yuko, Meerwein, Sebastian, Tanaka, Yoshiya

    Published in Arthritis research & therapy (06-01-2021)
    “…The objective of the study was to evaluate the efficacy and safety of upadacitinib over 84 weeks in Japanese patients with active rheumatoid arthritis (RA) and…”
    Get full text
    Journal Article
  16. 16

    First application of data assimilation-based control to fusion plasma by Morishita, Yuya, Murakami, Sadayoshi, Kenmochi, Naoki, Funaba, Hisamichi, Yamada, Ichihiro, Mizuno, Yoshinori, Nagahara, Kazuki, Nuga, Hideo, Seki, Ryosuke, Yokoyama, Masayuki, Ueno, Genta, Osakabe, Masaki

    Published in Scientific reports (17-01-2024)
    “…Magnetic fusion plasmas, which are complex systems comprising numerous interacting elements, have large uncertainties. Therefore, future fusion reactors…”
    Get full text
    Journal Article
  17. 17

    Polymeric Micelles Possessing Polyethyleneglycol as Outer Shell and Their Unique Behaviors in Accelerated Blood Clearance Phenomenon by Shiraishi, Kouichi, Yokoyama, Masayuki

    Published in Biological & pharmaceutical bulletin (01-06-2013)
    “…Polymeric micelles are assemblies of synthetic polymers and have been studied and developed as drug carriers for targeting. Polymeric micelles are composed of…”
    Get full text
    Journal Article
  18. 18

    PEG‐poly(L‐lysine)‐based polymeric micelle MRI contrast agent: Feasibility study of a Gd‐micelle contrast agent for MR lymphography by Akai, Hiroyuki, Shiraishi, Kouichi, Yokoyama, Masayuki, Yasaka, Koichiro, Nojima, Masanori, Inoue, Yusuke, Abe, Osamu, Ohtomo, Kuni, Kiryu, Shigeru

    Published in Journal of magnetic resonance imaging (01-01-2018)
    “…Purpose To investigate the feasibility of polymeric micelle of poly(ethyleneglycol) (PEG)‐b‐poly(L‐lysine‐DOTA) (Gd‐micelle) as a contrast agent for magnetic…”
    Get full text
    Journal Article
  19. 19

    Size-dependent induction of accelerated blood clearance phenomenon by repeated injections of polymeric micelles by Koide, Hiroyuki, Asai, Tomohiro, Kato, Hiroki, Ando, Hidenori, Shiraishi, Kouichi, Yokoyama, Masayuki, Oku, Naoto

    Published in International journal of pharmaceutics (01-08-2012)
    “…An accelerated blood clearance (ABC) phenomenon is induced by repeated injections of poly(ethylene glycol)-modified (PEGylated) liposomes. We previously…”
    Get full text
    Journal Article
  20. 20